Histamine Phosphate is one of 133 small molecule programs targeting Allergic Rhinitis. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
FDA Application
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
91 competitors in ART
Belamaf
Venclexta
Rituxan
Attruby
Brukinsa
Treanda
Toradol
Cysteine Hydrochloride
Noradrenaline
Vyvgart
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Regulatory
Jan 1, 1982
HISTAMINE PHOSPHATE
NDA NDA000734
Sources